Development of new therapeutic strategies for Parkinson's disease based on replacement of L-DOPA using rAAV vectors

被引：0
|
作者：
Kirik, D. [1 ]
机构：
[1] Lund Univ, Dept Expt Med Sci, Sect Neurosci, CNS Dis Modeling Unit, Lund, Sweden
来源：
CELL TRANSPLANTATION | 2006年 / 15卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
引用
收藏
页码：561 / 561
页数：1
相关论文
共 50 条
  • [21] L-DOPA for Parkinson's disease-a bittersweet pill
    Lane, Emma L.
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2019, 49 (03) : 384 - 398
  • [22] L-DOPA: A scapegoat for accelerated neurodegeneration in Parkinson's disease?
    Lipski, Janusz
    Nistico, Robert
    Berretta, Nicola
    Guatteo, Ezia
    Bernardi, Giorgio
    Mercuri, Nicola B.
    PROGRESS IN NEUROBIOLOGY, 2011, 94 (04) : 389 - 407
  • [23] Parkinson's disease: Progression and mortality in the L-DOPA era
    DiRocco, A
    Molinari, SP
    Kollmeier, B
    Yahr, MD
    PARKINSON'S DISEASE, 1996, 69 : 3 - 11
  • [24] L-dopa impairs associative learning in Parkinson's disease
    Shohamy, D
    Myers, CE
    Onlaor, S
    Gluck, MA
    JOURNAL OF COGNITIVE NEUROSCIENCE, 2002, : 84 - 84
  • [25] Treatment strategies in Parkinson's disease after a quarter century experiences with L-DOPA therapy
    Fischer, PA
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1995, (46): : 381 - 389
  • [26] The effects of L-Dopa on attention in Parkinson's disease and Parkinson's dementia patients
    Molloy, S
    McKeith, IG
    Burn, D
    Wesnes, KA
    JOURNAL OF PSYCHOPHARMACOLOGY, 2004, 18 (03) : A51 - A51
  • [27] The effects of L-dopa on attention in Parkinson's disease and Parkinson's dementia patients
    Molloy, S.
    McKeith, I. G.
    Burn, D.
    Wesnes, K. A.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 294 - 294
  • [28] The effects of different repeated doses of entacapone on the pharmacokinetics of L-Dopa and on the clinical response to L-Dopa in Parkinson's disease
    Heikkinen, H
    Nutt, JG
    LeWitt, PA
    Koller, WC
    Gordin, A
    CLINICAL NEUROPHARMACOLOGY, 2001, 24 (03) : 150 - 157
  • [29] Conversion of L-dopa to Extended Release L-dopa (Rytary®) in Patients with Fluctuating Parkinson's Disease: Predictors of Dose
    Ondo, William
    Coss, Pablo
    Christie, Melissa
    Pascual, Belen
    JOURNAL OF PARKINSONS DISEASE, 2019, 9 (01) : 153 - 156
  • [30] Interactions between cognition, depression and L-dopa in Parkinson's disease
    Degroot, C.
    Bruneau, M. A.
    Mejia-Constain, B.
    Bedetti, C.
    Monchi, O.
    MOVEMENT DISORDERS, 2012, 27 : S280 - S280
12345